Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroectodermal Tumors”

8,185 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,185 results

Not applicableEnrolling By InvitationNCT02270567
What this trial is testing

RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

Who this might be right for
Neuroendocrine TumorCarcinoidNeuroendocrine Carcinoma
Wren Laboratories LLC 400
Not applicableStudy completedNCT00857519
What this trial is testing

The Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma

Who this might be right for
Retinoblastoma
Wills Eye 10
Large-scale testing (Phase 3)Study completedNCT01866319
What this trial is testing

Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 834
Large-scale testing (Phase 3)Ended earlyNCT01006252
What this trial is testing

Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma

Who this might be right for
Melanoma
Eli Lilly and Company 336
Not applicableEnded earlyNCT00416949
What this trial is testing

Iodine I 131 in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT03200847
What this trial is testing

Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaAdvanced Melanoma
University of Colorado, Denver 26
Early research (Phase 1)Not Yet RecruitingNCT04903795
What this trial is testing

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Who this might be right for
Newly Diagnosed GlioblastomaRecurrent Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 18
Testing effectiveness (Phase 2)Study completedNCT00028795
What this trial is testing

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Oncology Group 170
Not applicableEnrolling By InvitationNCT07316075
What this trial is testing

Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and Paragangliomas

Who this might be right for
Cardiovascular AbnormalitiesArterial Blood PressureHeart Rate+6 more
Laikο General Hospital, Athens 50
Early research (Phase 1)UnknownNCT03231501
What this trial is testing

HMPL-813 in Treating Patients With Glioblastoma

Who this might be right for
Glioblastoma
Hutchison Medipharma Limited 29
Not applicableWithdrawnNCT02306512
What this trial is testing

Mohs and Immunofluorescence for Malignant Melanoma In Situ

Who this might be right for
Lentigo MalignaMelanoma In Situ
University of Miami
Very early researchLooking for participantsNCT05773326
What this trial is testing

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Who this might be right for
High Grade GliomaGliomaGlioma, Malignant+1 more
Nader Sanai 12
Not applicableWithdrawnNCT04667715
What this trial is testing

Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glioma

Who this might be right for
Glioma
InSightec
Testing effectiveness (Phase 2)Ended earlyNCT01973608
What this trial is testing

MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma

Who this might be right for
Melanoma
EMD Serono 12
Testing effectiveness (Phase 2)Study completedNCT01967576
What this trial is testing

Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma

Who this might be right for
PheochromocytomaParaganglioma
National Cancer Institute (NCI) 14
Not applicableEnded earlyNCT01954576
What this trial is testing

NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
GlioblastomaBrain Neoplasms
University of Florida 21
Testing effectiveness (Phase 2)Study completedNCT00501891
What this trial is testing

Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma

Who this might be right for
Glioblastoma Multiforme
Duke University 32
Testing effectiveness (Phase 2)Ended earlyNCT01723813
What this trial is testing

Peptide Vaccinations Plus GM-CT-01 in Melanoma

Who this might be right for
Metastatic Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Early research (Phase 1)Study completedNCT01729260
What this trial is testing

Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide

Who this might be right for
Newly Diagnosed High-Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Not applicableStudy completedNCT03628417
What this trial is testing

Confirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous Metastases

Who this might be right for
Cutaneous Melanoma
Szeged University 7
Load More Results